Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public.
Important Status Update:
As of March 21, 2023, the majority of all YSM and YM policies, procedures, and guidelines will be made available via a new document management system. Please contact Parami Hettiarachchi, Senior Policy Analyst, with questions. Get help with PolicyTech.
IND, IDE or EUA-related protocols policy
YCCI provides a comprehensive, centralized resource for FDA submission of Investigational New Drug (IND) applications and Investigational Device Exemptions (IDEs), with staff members and consultants with Industry experience who provide “soup to nuts” IND/IDE support.